These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24681409)

  • 1. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
    Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP
    J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
    de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
    J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
    Makawita S; Smith C; Batruch I; Zheng Y; Rückert F; Grützmann R; Pilarsky C; Gallinger S; Diamandis EP
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.008599. PubMed ID: 21653254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
    Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.
    Cevenini A; Orrù S; Imperlini E
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics for discovery of candidate colorectal cancer biomarkers.
    Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
    World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
    Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
    J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.
    Barderas R; Mendes M; Torres S; Bartolomé RA; López-Lucendo M; Villar-Vázquez R; Peláez-García A; Fuente E; Bonilla F; Casal JI
    Mol Cell Proteomics; 2013 Jun; 12(6):1602-20. PubMed ID: 23443137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
    Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
    PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
    Ludvigsen M; Thorlacius-Ussing L; Vorum H; Stender MT; Thorlacius-Ussing O; Honoré B
    Curr Issues Mol Biol; 2021 Sep; 43(2):1043-1056. PubMed ID: 34563043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.
    Albrethsen J; Knol JC; Piersma SR; Pham TV; de Wit M; Mongera S; Carvalho B; Verheul HM; Fijneman RJ; Meijer GA; Jimenez CR
    Mol Cell Proteomics; 2010 May; 9(5):988-1005. PubMed ID: 20089989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
    Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
    J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry.
    Kang UB; Yeom J; Kim HJ; Kim H; Lee C
    J Proteomics; 2012 Jun; 75(10):3050-62. PubMed ID: 22154799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.